Showing results (4191-4200 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|January 1, 1988
Imidazole salicylate in the treatment of osteoarthrosis and musculoskeletal trauma: a postmarketing surveyI Scaricabarozzi, B Chinea, A ScottiClinical Therapeutics|April 23, 2021
Evaluating the Risk of Digitalis Intoxication Associated With Concomitant Use of Dronedarone and Digoxin Using Real-World DataChuntao Wu, Rania Boiron, Hayet Kechemir, et al.Clinical Therapeutics|July 6, 2020
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature ReviewElias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf, et al.Clinical Therapeutics|July 6, 2020
A Thorough QT Study of the Combination Glecaprevir + Pibrentasvir on Cardiac Repolarization in Healthy SubjectsRajneet K Oberoi, Weihan Zhao, Matthew Rosebraugh, et al.Clinical Therapeutics|April 22, 2021
Transparency in European Medicines Agency and US Food and Drug Administration Decision Making: Is It Possible to Identify the Rationale for Divergences in Approved Indication From Public Assessment Reports?Magda Bujar, Sara Ferragu, Neil McAuslane, et al.Clinical Therapeutics|April 3, 2021
Efficacy and Safety of Bivalirudin During Percutaneous Coronary Intervention in Chronic Total Occlusion: A Retrospective StudyYanghui Zhang, Yahao Zhang, Chao Chang, et al.Clinical Therapeutics|January 1, 1986
Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic childrenM M Logvinoff, D B Weinstein, M T Watts, et al.Clinical Therapeutics|January 1, 1986
Effects of diltiazem on PR intervals in healthy young adultsH Araki, N Hotokebuchi, T Ohta, et al.Clinical Therapeutics|January 5, 2002
Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysisA Marchetti, R Magar, H Lau, et al.Pageof 680